TALPHERA, INC. Proceeds from Sale and Maturity of Marketable Securities
TALPHERA, INC. (TLPH) reported Proceeds from Sale and Maturity of Marketable Securities of $0 for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2025-05-14
- TALPHERA, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- TALPHERA, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2024-12-31 was $0.00.
- TALPHERA, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2024-09-30 was $600.00K.
- TALPHERA, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2024-06-30 was $6.66M.
- TALPHERA, INC. proceeds from sale and maturity of marketable securities for fiscal 2024 was $8.76M, a 1652.00% increase from fiscal 2023.
- TALPHERA, INC. proceeds from sale and maturity of marketable securities for fiscal 2023 was $500.00K, a 98.92% decline from fiscal 2022.
- TALPHERA, INC. proceeds from sale and maturity of marketable securities for fiscal 2022 was $46.36M.
- TALPHERA, INC. proceeds from sale and maturity of marketable securities for fiscal 2020 was $80.61M, a 20.35% increase from fiscal 2019.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month | Proceeds from Sale and Maturity of Marketable Securities 78 month | Proceeds from Sale and Maturity of Marketable Securities 81 month | Proceeds from Sale and Maturity of Marketable Securities 84 month | Proceeds from Sale and Maturity of Marketable Securities 87 month | Proceeds from Sale and Maturity of Marketable Securities 90 month | Proceeds from Sale and Maturity of Marketable Securities 93 month | Proceeds from Sale and Maturity of Marketable Securities 96 month | Proceeds from Sale and Maturity of Marketable Securities 99 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-05-14 | $600.00K derived: sum of 3 quarters · filed 2025-05-14 | $7.26M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $600.00K derived: sum of 2 quarters · filed 2025-03-31 | $7.26M derived: sum of 3 quarters · filed 2025-03-31 | $8.76M 10-K · filed 2025-03-31 | ||||||||
| 2024-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $7.26M derived: sum of 2 quarters · filed 2024-11-13 | $8.76M 10-Q · filed 2024-11-13 | $8.76M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||
| 2024-06-30 | $6.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $8.16M 10-Q · filed 2024-08-14 | $8.16M derived: sum of 3 quarters · filed 2025-05-14 | $8.16M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||
| 2024-03-31 | $1.50M 10-Q · filed 2025-05-14 | $1.50M derived: sum of 2 quarters · filed 2025-05-14 | $1.50M derived: sum of 3 quarters · filed 2025-05-14 | $1.50M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $500.00K 10-K · filed 2025-03-31 | ||||||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $500.00K 10-Q · filed 2024-11-13 | $3.70M derived: sum of 4 quarters · filed 2024-11-13 | ||||||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $500.00K 10-Q · filed 2024-08-14 | $3.70M derived: sum of 3 quarters · filed 2024-08-14 | $8.30M derived: sum of 4 quarters · filed 2024-08-14 | ||||||||
| 2023-03-31 | $500.00K 10-Q · filed 2024-05-14 | $3.70M derived: sum of 2 quarters · filed 2024-05-14 | $8.30M derived: sum of 3 quarters · filed 2024-05-14 | $19.27M derived: sum of 4 quarters · filed 2024-05-14 | ||||||||
| 2022-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $7.80M derived: sum of 2 quarters · filed 2024-03-06 | $18.77M derived: sum of 3 quarters · filed 2024-03-06 | $46.36M 10-K · filed 2024-03-06 | ||||||||
| 2022-09-30 | $4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $15.57M derived: sum of 2 quarters · filed 2023-11-14 | $43.16M 10-Q · filed 2023-11-14 | $53.17M derived: sum of 4 quarters · filed 2023-11-14 | ||||||||
| 2022-06-30 | $10.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $38.56M 10-Q · filed 2023-08-10 | $48.57M derived: sum of 3 quarters · filed 2023-08-10 | $57.77M derived: sum of 4 quarters · filed 2023-08-10 | ||||||||
| 2022-03-31 | $27.60M 10-Q · filed 2023-05-10 | $37.60M derived: sum of 2 quarters · filed 2023-08-01 | $46.80M derived: sum of 3 quarters · filed 2023-08-01 | $64.54M derived: sum of 4 quarters · filed 2023-08-01 | ||||||||
| 2021-12-31 | $10.00M derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | $19.20M derived: sum of 2 quarters · filed 2023-08-01 | $36.95M derived: sum of 3 quarters · filed 2023-08-01 | $43.99M 8-K · filed 2023-08-01 | ||||||||
| 2021-09-30 | $9.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $26.94M derived: sum of 2 quarters · filed 2022-11-14 | $33.98M 10-Q · filed 2022-11-14 | $47.18M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||
| 2021-06-30 | $17.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $24.78M 10-Q · filed 2022-08-11 | $37.98M derived: sum of 3 quarters · filed 2022-08-11 | $46.83M derived: sum of 4 quarters · filed 2022-08-11 | ||||||||
| 2021-03-31 | $7.04M 10-Q · filed 2022-05-16 | $20.24M derived: sum of 2 quarters · filed 2022-05-16 | $29.09M derived: sum of 3 quarters · filed 2022-05-16 | $52.16M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||
| 2020-12-31 | $13.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $22.05M derived: sum of 2 quarters · filed 2022-03-10 | $45.13M derived: sum of 3 quarters · filed 2022-03-10 | $80.61M 10-K · filed 2022-03-10 | ||||||||
| 2020-09-30 | $8.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $31.93M derived: sum of 2 quarters · filed 2021-11-15 | $67.41M 10-Q · filed 2021-11-15 | $92.68M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||
| 2020-06-30 | $23.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $58.55M 10-Q · filed 2021-08-16 | $83.83M derived: sum of 3 quarters · filed 2021-08-16 | $105.83M derived: sum of 4 quarters · filed 2021-08-16 | ||||||||
| 2020-03-31 | $35.48M 10-Q · filed 2021-05-17 | $60.76M derived: sum of 2 quarters · filed 2021-05-17 | $82.75M derived: sum of 3 quarters · filed 2021-05-17 | $97.56M derived: sum of 4 quarters · filed 2021-05-17 | ||||||||
| 2019-12-31 | $25.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $47.27M derived: sum of 2 quarters · filed 2021-03-15 | $62.08M derived: sum of 3 quarters · filed 2021-03-15 | $66.97M 10-K · filed 2021-03-15 | ||||||||
| 2019-09-30 | $22.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $36.80M derived: sum of 2 quarters · filed 2020-11-05 | $41.70M 10-Q · filed 2020-11-05 | $47.70M derived: sum of 4 quarters · filed 2021-03-15 | ||||||||
| 2019-06-30 | $14.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $19.70M 10-Q · filed 2020-08-10 | $25.70M derived: sum of 3 quarters · filed 2021-03-15 | $36.60M derived: sum of 4 quarters · filed 2021-03-15 | ||||||||
| 2019-03-31 | $4.90M 10-Q · filed 2020-05-11 | $10.90M derived: sum of 2 quarters · filed 2021-03-15 | $21.80M derived: sum of 3 quarters · filed 2021-03-15 | $24.40M derived: sum of 4 quarters · filed 2021-03-15 | ||||||||
| 2018-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $16.90M derived: sum of 2 quarters · filed 2021-03-15 | $19.50M derived: sum of 3 quarters · filed 2021-03-15 | $20.50M 10-K · filed 2021-03-15 | ||||||||
| 2018-09-30 | $10.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $13.50M derived: sum of 2 quarters · filed 2019-11-07 | $14.50M 10-Q · filed 2019-11-07 | |||||||||
| 2018-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $3.60M 10-Q · filed 2019-08-06 | ||||||||||
| 2018-03-31 | $1.00M 10-Q · filed 2019-05-09 | |||||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $1.00M derived: sum of 2 quarters · filed 2019-03-07 | $2.72M derived: sum of 3 quarters · filed 2019-03-07 | $6.53M 10-K · filed 2019-03-07 | ||||||||
| 2016-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.72M derived: sum of 2 quarters · filed 2017-11-09 | $6.53M 10-Q · filed 2017-11-09 | $10.24M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||
| 2016-06-30 | $1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $5.53M 10-Q · filed 2017-08-02 | $9.24M derived: sum of 3 quarters · filed 2018-03-09 | $16.99M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||
| 2016-03-31 | $3.81M 10-Q · filed 2017-05-08 | $7.52M derived: sum of 2 quarters · filed 2018-03-09 | $15.27M derived: sum of 3 quarters · filed 2018-03-09 | $18.26M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||
| 2015-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $11.46M derived: sum of 2 quarters · filed 2018-03-09 | $14.46M derived: sum of 3 quarters · filed 2018-03-09 | $16.93M 10-K · filed 2018-03-09 | ||||||||
| 2015-09-30 | $7.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $10.74M derived: sum of 2 quarters · filed 2016-11-02 | $13.21M 10-Q · filed 2016-11-02 | $15.74M derived: sum of 4 quarters · filed 2017-03-03 | ||||||||
| 2015-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $5.46M 10-Q · filed 2016-07-29 | $7.99M derived: sum of 3 quarters · filed 2017-03-03 | $17.24M derived: sum of 4 quarters · filed 2017-03-03 | ||||||||
| 2015-03-31 | $2.47M 10-Q · filed 2016-05-02 | $5.00M derived: sum of 2 quarters · filed 2017-03-03 | $14.25M derived: sum of 3 quarters · filed 2017-03-03 | $18.37M derived: sum of 4 quarters · filed 2017-03-03 | ||||||||
| 2014-12-31 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $11.78M derived: sum of 2 quarters · filed 2017-03-03 | $15.90M derived: sum of 3 quarters · filed 2017-03-03 | $17.16M 10-K · filed 2017-03-03 | ||||||||
| 2014-09-30 | $9.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $13.37M derived: sum of 2 quarters · filed 2015-11-03 | $14.63M 10-Q · filed 2015-11-03 | $16.77M derived: sum of 4 quarters · filed 2016-03-07 | ||||||||
| 2014-06-30 | $4.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $5.38M 10-Q · filed 2015-08-04 | $7.52M derived: sum of 3 quarters · filed 2016-03-07 | $14.91M derived: sum of 4 quarters · filed 2016-03-07 | ||||||||
| 2014-03-31 | $1.26M 10-Q · filed 2015-05-05 | $3.40M derived: sum of 2 quarters · filed 2016-03-07 | $10.79M derived: sum of 3 quarters · filed 2016-03-07 | $16.59M derived: sum of 4 quarters · filed 2016-03-07 | ||||||||
| 2013-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-07 | $9.53M derived: sum of 2 quarters · filed 2016-03-07 | $15.33M derived: sum of 3 quarters · filed 2016-03-07 | $24.38M 10-K · filed 2016-03-07 | ||||||||
| 2013-09-30 | $7.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $13.19M derived: sum of 2 quarters · filed 2014-11-10 | $22.23M 10-Q · filed 2014-11-10 | $33.65M derived: sum of 4 quarters · filed 2015-03-13 | $99.90M 10-Q · filed 2013-11-05 | |||||||
| 2013-06-30 | $5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $14.85M 10-Q · filed 2014-08-11 | $26.27M derived: sum of 3 quarters · filed 2015-03-13 | $34.36M derived: sum of 4 quarters · filed 2015-03-13 | $92.51M 10-Q · filed 2013-08-12 | |||||||
| 2013-03-31 | $9.04M 10-Q · filed 2014-05-08 | $20.47M derived: sum of 2 quarters · filed 2015-03-13 | $28.56M derived: sum of 3 quarters · filed 2015-03-13 | $36.80M derived: sum of 4 quarters · filed 2015-03-13 | $86.71M 10-Q · filed 2013-05-08 | |||||||
| 2012-12-31 | $11.42M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $19.51M derived: sum of 2 quarters · filed 2015-03-13 | $27.76M derived: sum of 3 quarters · filed 2015-03-13 | $42.95M 10-K · filed 2015-03-13 | $77.66M 10-K · filed 2013-03-12 | |||||||
| 2012-09-30 | $8.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $16.34M derived: sum of 2 quarters · filed 2013-11-05 | $31.53M 10-Q · filed 2013-11-05 | $37.74M derived: sum of 4 quarters · filed 2014-03-17 | $66.24M 10-Q · filed 2012-11-06 | |||||||
| 2012-06-30 | $8.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $23.43M 10-Q · filed 2013-08-12 | $29.64M derived: sum of 3 quarters · filed 2014-03-17 | $31.84M derived: sum of 4 quarters · filed 2014-03-17 | $58.15M 10-Q · filed 2012-08-10 | |||||||
| 2012-03-31 | $15.19M 10-Q · filed 2013-05-08 | $21.40M derived: sum of 2 quarters · filed 2014-03-17 | $23.60M derived: sum of 3 quarters · filed 2014-03-17 | $24.28M derived: sum of 4 quarters · filed 2014-03-17 | $49.91M 10-Q · filed 2012-05-09 | |||||||
| 2011-12-31 | $6.21M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $8.41M derived: sum of 2 quarters · filed 2014-03-17 | $9.09M derived: sum of 3 quarters · filed 2014-03-17 | $9.72M 10-K · filed 2014-03-17 | $34.72M 10-K · filed 2012-03-23 | |||||||
| 2011-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $2.88M derived: sum of 2 quarters · filed 2012-11-06 | $3.52M 10-Q · filed 2012-11-06 | |||||||||
| 2011-06-30 | $680.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $1.32M 10-Q · filed 2012-08-10 | ||||||||||
| 2011-03-31 | $636.00K 10-Q · filed 2012-05-09 | |||||||||||
| 2010-12-31 | $9.69M 10-K · filed 2013-03-12 | |||||||||||
| 2009-12-31 | $2.90M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |